MCAM and Alzheimer disease: Additionally, our study reveals new information regarding proteins consistently altered in AD, including SPARC (SPRC), Kininogen-1 (KNG1) or Cell surface glycoprotein MUC18 (MUC18), whose role as potential CSF biomarkers for AD has not been investigated.